Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10

Leukemia Research

Volumn 31, Issue 1, 2007, Pages 19-26

  Galili, Naomi ^a   Sechman, Eric V ^a   Cerny, Jan ^a   Mehdi, Murtaza ^a   Mumtaz, Muhammad ^a   Westervelt, Peter ^a   Maguire, Jessica ^a   Raza, Azra ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Coenzyme Q10; Mitochondria; mtDNA; Myelodysplastic syndromes

Indexed keywords

MITOCHONDRIAL DNA; UBIDECARENONE;

ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CYTOGENETICS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENE MUTATION; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; BONE MARROW CELLS; DNA, MITOCHONDRIAL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES; THROMBOCYTOPENIA; UBIQUINONE;

EID: 33750719425     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.04.009     Document Type: Article

References (12)

1. Raza A., Qawi H., Mehdi M., Mumtaz M., and Galili N. Translational research in myelodysplastic syndromes. Rev Clin Exp Hematol 8 2 (2004) E2
2. List A.F., Vardiman J., Issa J.-P.J., and DeWitte T.M. Myelodysplastic syndromes. Am Soc Hematol Educ Progr (2004) 297-317
3. Ernster L., and Dallner G. Biochemical, biophysical, and medical aspects of ubiquinone function. Biochem Biophys Acta 1271 (1995) 195-204
4. Papucci L., Schiavone N., Witwort E., Donnini M., Lapucci A., Tempestini A., et al. Coenzyme Q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavanging property. J Bio Chem 30 278 (2003 July) 28220-28228
5. Mosca L., Marcellini S., Perluigi M., Mastroiacovo P., Moretti S., Famularo G., et al. Modulation of apoptosis and improved redox metabolism with the use of a new antioxidant formula. Biochem Pharmacol 63 7 (2002 Apr 1) 1305-1314
6. Forsmark-Andree P., and Ernster L. Evidence for a protective effect of endogenous ubiquinol against oxidative damage to mitochondrial protein and DNA during lipid peroxidation. Mol Aspects Med 15 Suppl (1994) s73-s81
7. Crane F.L. Biochemical functions of coenzyme Q10. J Am Coll Nutr 20 6 (2001) 591-598
8. Henriksen J.E., Andersen C.B., Hother-Nielsen O., Vaag A., Mortensen S.A., and Beck-Nielsen H. Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus. Diabet Med 16 4 (1999) 312-318
9. Eriksson J.G., Forsen T.J., Mortensen S.A., and Rohde M. The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus. Biofactors 9 2-4 (1999) 315-318
10. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., et al., Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59 10 (2002 Oct) 1541-1550
11. Gattermann N. From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes. Leuk Res 24 2 (2000) 141-151
12. Reddy P.L., Shetty V.T., Dutt D., York A., Dar S., Mundle S.D., et al. Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes. Brit J Haematol 116 3 (2002 Mar) 564-575